Skip to main content

Rezvoglar Prices, Coupons and Patient Assistance Programs

Rezvoglar (insulin glargine) is a member of the insulin drug class and is commonly used for Diabetes - Type 1, and Diabetes - Type 2.

The cost for Rezvoglar subcutaneous solution (aglr 100 units/mL) is around $106 for a supply of 15 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Rezvoglar prices

Subcutaneous Solution

Quantity Per unit Price
15 (5 x 3 milliliters) $7.09 $106.38

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Rezvoglar Coupons, Copay Cards and Rebates

Rezvoglar offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Lilly Insulin Value Program Cash Savings Card for Rezvoglar KwikPen

Eligible uninsured/cash-paying patients may pay as little as $35 per 30-day prescription; offer valid for up to 12 calendar months; annual maximum savings of $16,000; card expires at end of each calendar year; for more information contact the program at 833-808-1234.

Applies to:
Rezvoglar KwikPen
Number of uses:
12 times within calendar year
Expires
December 31, 2024

Form more information phone: 833-808-1234 or Visit website

Lilly Insulin Value Program Commercial Insurance Savings Card for Rezvoglar KwikPen

Eligible commercially insured patients may pay as little as $35 per 30-day prescription; offer valid for up to 12 calendar months; annual maximum savings of $16,000; card expires at end of each calendar year; for more information contact the program at 833-808-1234.

Applies to:
Rezvoglar KwikPen
Number of uses:
12 times within calendar year
Expires
December 31, 2024

Form more information phone: 833-808-1234 or Visit website

Patient Assistance & Copay Programs for Rezvoglar

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Rezvoglar KwikPen (insulin glargine-aglr) Injection

More information please phone: 866-316-7263 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.